Abstract Background The prevalence of Rheumatic Mitral Stenosis (MS) has significantly changed over the last decades. We intend to examine patient demographics, Echocardiographic characteristics, procedural success rates, and complications throughout 30-years. Methods conducted a single-center descriptive observational study. study population consists patients undergone percutaneous balloon mit...

To evaluate left-to-right shunts after percutaneous balloon mitral valvuloplasty, we studied 15 consecutive patients by using transesophageal color Doppler flow-imaging system. Transesophageal color Doppler examinations were performed five times in each patient (before valvuloplasty and 1 day, 1 week, 1 month, and 6 months after valvuloplasty). No shunt flow was observed before valvuloplasty. O...

Mitral stenosis (MS) is generally the sequel of rheumatic carditis occurring in childhood (1). MS is particularly observed in developing countries (1, 2). Untreated patients can develop irreversible right ventricular failure (1, 2). Since its introduction by Inoue, percutaneous mitral balloon valvuloplasty (PMBV) is considered the leading and effective treatment option for symptomatic moderate ...

This study is designed to test whether percutaneous balloon mitral valvuloplasty (PBMV) is effective for rheumatic mitral stenosis in Chinese patients with moderate to severe mitral regurgitation. Fifty-six patients with rheumatic mitral valve stenosis were divided into the mild, moderate, and severe regurgitation groups. Cardiac ultrasonography was measured before and 1 to 2 days after PBMV. F...